Werewolf Therapeutics Ownership | Who Owns Werewolf Therapeutics?


OverviewForecastRevenueFinancialsChart

Werewolf Therapeutics Ownership Summary


Werewolf Therapeutics is owned by 73.14% institutional investors, 6.11% insiders, and 20.75% retail investors. Ra capital management is the largest institutional shareholder, holding 14.77% of HOWL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.83% of its assets in Werewolf Therapeutics shares.

HOWL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockWerewolf Therapeutics73.14%6.11%20.75%
SectorHealthcare Stocks 49.65%8.78%41.57%
IndustryBiotech Stocks 46.85%8.74%44.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management6.14M14.77%$14.99M
Mpm asset management4.28M10.30%$10.45M
Pfm health sciences, lp3.24M7.79%$7.91M
Bioimpact capital2.39M5.74%$5.83M
Bank of america corp /de/2.15M5.16%$5.24M
Adage capital partners gp2.00M4.81%$4.88M
Blackrock1.59M3.82%$3.87M
Rubric capital management lp1.33M3.21%$3.25M
Vanguard group1.32M3.18%$3.23M
Millennium management1.11M2.67%$2.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Dc funds, lp589.10K23.87%$1.44M
Mpm asset management4.28M5.74%$10.45M
Bioimpact capital2.39M0.91%$5.83M
Pfm health sciences, lp3.24M0.39%$7.91M
Eagle health investments lp700.00K0.30%$1.71M
Sphera funds management626.81K0.21%$1.53M
Ra capital management6.14M0.20%$14.99M
Rubric capital management lp1.33M0.09%$3.25M
Adage capital partners gp2.00M0.01%$4.88M
Bridgeway capital management125.09K0.01%$305.21K

Top Buyers

HolderShares% AssetsChange
Blackrock1.59M0.00%1.42M
Millennium management1.11M0.00%544.88K
Geode capital management645.30K0.00%385.62K
State street423.91K-352.74K
Bank of america corp /de/2.15M0.00%266.31K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp2.00M0.01%-1.00M
Monashee investment management---890.00K
Rubric capital management lp1.33M0.09%-287.14K
Verition fund management---233.83K
Laurion capital management lp---201.24K

New Positions

HolderShares% AssetsChangeValue
Walleye capital98.44K0.00%98.44K$240.19K
Charles schwab investment management78.84K-78.84K$192.37K
Bank of new york mellon67.64K-67.64K$165.05K
Point72 asset management52.20K0.00%52.20K$127.37K
Nuveen asset management52.05K-52.05K$127.00K

Sold Out

HolderChange
Simplex trading-202.00
Macquarie group-940.00
Qube research-8.31K
Paloma partners management-10.04K
Balyasny asset management-10.46K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202469-4.17%31,964,492-0.84%731.22%38-15.56%12-7.69%
Jun 30, 20247214.29%32,236,039-0.05%771.00%4515.38%138.33%
Mar 31, 20246346.51%32,252,02716.56%881.46%3969.57%1271.43%
Dec 31, 20234322.86%27,669,99915.86%771.72%2376.92%775.00%
Sep 30, 202335-2.78%23,883,269-0.67%671.41%138.33%433.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv800.28K1.83%-
iShares Russell 2000 ETF676.89K1.55%-1.53K
HBM Healthcare Investments AG Ord396.80K0.91%-60.51K
Vanguard Institutional Extnd Mkt Idx Tr392.16K0.90%-
Fidelity Small Cap Index310.65K0.71%-6.09K
BIT Biotech Opportunities S233.37K0.53%-
iShares Russell 2000 Value ETF211.77K0.48%-
Fidelity Extended Market Index175.15K0.40%16.24K
State St Russell Sm Cap® Indx SL Cl I157.50K0.36%-
Vanguard Russell 2000 ETF139.09K0.32%-844.00

Recent Insider Transactions


DateNameRoleActivityValue
Jan 06, 2023RA CAPITAL MANAGEMENT, L.P.-Buy$4.10M
Dec 15, 2021Leonard Reid Chief Operating OfficerSell$1.89K
Dec 15, 2021Leonard Reid Chief Operating OfficerSell$38.36K
Jun 15, 2021RA CAPITAL MANAGEMENT, L.P. Buy$103.06K
Jun 16, 2021RA CAPITAL MANAGEMENT, L.P. Buy$124.14K

Insider Transactions Trends


DateBuySell
2024 Q2--
2024 Q1--
2023 Q2--
2023 Q11-
2022 Q2--

HOWL Ownership FAQ


Who Owns Werewolf Therapeutics?

Werewolf Therapeutics shareholders are primarily institutional investors at 73.14%, followed by 6.11% insiders and 20.75% retail investors. The average institutional ownership in Werewolf Therapeutics's industry, Biotech Stocks , is 46.85%, which Werewolf Therapeutics exceeds.

Who owns the most shares of Werewolf Therapeutics?

Werewolf Therapeutics’s largest shareholders are Ra capital management (6.14M shares, 14.77%), Mpm asset management (4.28M shares, 10.30%), and Pfm health sciences, lp (3.24M shares, 7.79%). Together, they hold 32.86% of Werewolf Therapeutics’s total shares outstanding.

Does Blackrock own Werewolf Therapeutics?

Yes, BlackRock owns 3.82% of Werewolf Therapeutics, totaling 1.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.87M$. In the last quarter, BlackRock increased its holdings by 1.42M shares, a 863.47% change.

Who is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested?

Dc funds, lp is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested, with 23.87% of its assets in 589.1K Werewolf Therapeutics shares, valued at 1.44M$.

Who is the top mutual fund holder of Werewolf Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Werewolf Therapeutics shares, with 1.83% of its total shares outstanding invested in 800.28K Werewolf Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools